Dupuytren Contracture Institute

Nattokinase

17 published studies in Japan and in the U.S. show that nattokinase has the potential to reduce the scar in its early development stages, as in Dupuytren contracture.

Everyone wants a pure, potent source of nattokinase, and this is a massive 1500 fibrin units (FU) per two tablet serving. 17 published studies in Japan and in the U.S. show that nattokinase has the potential to take care of the scar in its early stages, and even later, as well as improving circulation. For over 50 years the German company, Wobenzym, has studied and published more research material about nattokinase than any other enzyme manufacturer in the world, making nattokinase “the single-most researched enzyme product” in the world.